Trellis Bioscience Revenue and Competitors

Location

N/A

Total Funding

Fintech

Industry

Estimated Revenue & Valuation

  • Trellis Bioscience's estimated annual revenue is currently $2.1M per year.(i)
  • Trellis Bioscience's estimated revenue per employee is $91,000

Employee Data

  • Trellis Bioscience has 23 Employees.(i)
  • Trellis Bioscience grew their employee count by 5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M26-4%$15.7MN/A
#2
$1.4M21-50%$21.2MN/A
#3
$41.9M2938%$6MN/A
#4
$6M53-22%$216.8MN/A
#5
$0M20%$33.3MN/A
#6
$26M1820%N/AN/A
#7
$30.9M221-26%$64.6MN/A
#8
$28.6M205-22%$46.8MN/A
#9
$249.1M134015%$75MN/A
#10
$12.4M953%N/AN/A
Add Company

keywords:N/A

N/A

Total Funding

23

Number of Employees

$2.1M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Trellis Bioscience's People

NameTitleEmail/Phone
1
CSO & FounderReveal Email/Phone
2
CEO/PresidentReveal Email/Phone
3
COO, CTO & FounderReveal Email/Phone
4
VP Research and DevelopmentReveal Email/Phone
5
CMOReveal Email/Phone

Trellis Bioscience News

2022-04-19 - Human Cytomegalovirus Envelope Glycoprotein B Market Size 2022 ...

Trellis Bioscience; Inc. Vakzine Projekt Management GmbH; VBI Vaccine Inc; Vical Incorporated. Human Cytomegalovirus Envelope Glycoprotein B Market Breakdown by...

2022-04-17 - Respiratory Syncytial Virus Attachment Glycoprotein Latest Trend ...

Agilvax Inc., Bavarian Nordic A/S, Emergent BioSolutions Inc., F. Hoffmann-La Roche Ltd., Trellis Bioscience Inc. ... A recent report on the...

2022-04-17 - Hepatitis A Virus Cellular Receptor 2 Market to Witness Huge ...

... Interprotein Corp, Jounce Therapeutics Inc, Merus NV, Novartis AG, Sorrento Therapeutics Inc, Sutro Biopharma Inc, Tesaro Inc, Trellis Bioscience Inc.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.8M23-32%N/A
#2
$4.7M230%N/A
#3
$2.3M23N/AN/A
#4
$1.7M23N/AN/A
#5
$2.3M23N/AN/A

Trellis Bioscience Executives


NameTitle
Lawrence KauvarCSO & Founder
Stefan RyserCEO/President
Stote EllsworthCOO, CTO & Founder
Tony LeightonCMO
Stefan RyserCEO/President
Mikhail GishizkyVP Research and Development